Venrock partner Camille Samuels sits down with her fellow Unity board member Paul Berns to discuss his long career in the pharmaceuticals and biotechnology industries. He shares how he led Anacor to a $5B+ acquisition by Pfizer in 2016 and his approach to managing people (the most important variable for success) with intellectual honesty and a high EQ. They also discuss the history of Humira, the world’s largest drug, and how the patient ultimately shapes every business decision he makes.